Recently, it was shown that inhibition of c-FLIP overcomes acquired resistance to sorafenib by reducing endoplasmic reticulum stress (ERS)-related autophagy in hepatocellular carcinoma (HCC) [72]. This evidence concerns the gene CFLAR and hepatocellular carcinoma.